Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002373222 | SCV002624249 | pathogenic | Hereditary cancer-predisposing syndrome | 2019-07-22 | criteria provided, single submitter | clinical testing | The c.393_435dup43 variant, located in coding exon 3 of the MSH2 gene, results from a duplication of TGAAGACATTCTCTTTGGTAACAATGATATGTCAGCTTCCATT at nucleotide position 393, causing a translational frameshift with a predicted alternate stop codon (p.G146*). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |